Pharmaceutical exporters in India are raising alarms over significant customs delays at the Jawaharlal Nehru Port Trust (JNCH) in Nhava Sheva.
Industry representatives warn that the logistical bottlenecks are disrupting the movement of time-sensitive cargo, creating immediate operational friction for firms relying on the port for global distribution.
The body emphasized the critical nature of cold-chain integrity, noting that delays at the port directly threaten the viability of sensitive pharmaceutical shipments.
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has formally intervened, seeking detailed information on the challenges surrounding the handling of temperature-controlled consignments.
The body emphasized the critical nature of cold-chain integrity, noting that delays at the port directly threaten the viability of sensitive pharmaceutical shipments.
JNCH remains a critical node for India's export economy, particularly for the pharmaceutical sector which depends on rapid turnaround times to meet international regulatory and delivery standards.
Persistent delays at such a major hub can ripple through supply chains, increasing costs and risking compliance with strict global shipping windows.